{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:17:00Z","timestamp":1775801820970,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/nm1627","type":"journal-article","created":{"date-parts":[[2007,9,2]],"date-time":"2007-09-02T18:11:26Z","timestamp":1188756686000},"page":"1070-1077","source":"Crossref","is-referenced-by-count":503,"title":["Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL"],"prefix":"10.1038","volume":"13","author":[{"given":"Klaus W","family":"Wagner","sequence":"first","affiliation":[]},{"given":"Elizabeth A","family":"Punnoose","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Januario","sequence":"additional","affiliation":[]},{"given":"David A","family":"Lawrence","sequence":"additional","affiliation":[]},{"given":"Robert M","family":"Pitti","sequence":"additional","affiliation":[]},{"given":"Kate","family":"Lancaster","sequence":"additional","affiliation":[]},{"given":"Dori","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Melissa","family":"von Goetz","sequence":"additional","affiliation":[]},{"given":"Sharon Fong","family":"Yee","sequence":"additional","affiliation":[]},{"given":"Klara","family":"Totpal","sequence":"additional","affiliation":[]},{"given":"Ling","family":"Huw","sequence":"additional","affiliation":[]},{"given":"Viswanatham","family":"Katta","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Cavet","sequence":"additional","affiliation":[]},{"given":"Sarah G","family":"Hymowitz","sequence":"additional","affiliation":[]},{"given":"Lukas","family":"Amler","sequence":"additional","affiliation":[]},{"given":"Avi","family":"Ashkenazi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,9,2]]},"reference":[{"key":"BFnm1627_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial, N.N. & Korsmeyer, S.J. Cell death: critical control points. Cell 116, 205\u2013219 (2004).","journal-title":"Cell"},{"key":"BFnm1627_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1736","volume":"5","author":"SW Fesik","year":"2005","unstructured":"Fesik, S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5, 876\u2013885 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1627_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.1125948","volume":"312","author":"WS Dalton","year":"2006","unstructured":"Dalton, W.S. & Friend, S.H. Cancer biomarkers\u2014an invitation to the table. Science 312, 1165\u20131168 (2006).","journal-title":"Science"},{"key":"BFnm1627_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305\u20131308 (1998).","journal-title":"Science"},{"key":"BFnm1627_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nrc821","volume":"2","author":"A Ashkenazi","year":"2002","unstructured":"Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2, 420\u2013430 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1627_CR6","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"FC Kischkel","year":"1995","unstructured":"Kischkel, F.C. et al. Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579\u20135588 (1995).","journal-title":"EMBO J."},{"key":"BFnm1627_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","volume":"12","author":"FC Kischkel","year":"2000","unstructured":"Kischkel, F.C. et al. Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611\u2013620 (2000).","journal-title":"Immunity"},{"key":"BFnm1627_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"F Igney","year":"2002","unstructured":"Igney, F. & Krammer, P. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277\u2013288 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1627_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi, A. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155\u2013162 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm1627_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.coph.2004.02.006","volume":"4","author":"S Kelley","year":"2004","unstructured":"Kelley, S. & Ashkenazi, A. Targeting death receptors in cancer with Apo2L\/TRAIL. Curr. Opin. Pharmacol. 4, 333\u2013339 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnm1627_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm0302-274","volume":"8","author":"H LeBlanc","year":"2002","unstructured":"LeBlanc, H. et al. Tumor-cell resistance to death receptor\u2013induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med. 8, 274\u2013281 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1627_CR12","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1016\/j.bmc.2005.04.085","volume":"13","author":"H Hang","year":"2005","unstructured":"Hang, H. & Bertozzi, C. The chemistry and biology of mucin-type O-linked glycosylation. Bioorg. Med. Chem. 13, 5021\u20135034 (2005).","journal-title":"Bioorg. Med. Chem."},{"key":"BFnm1627_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/BC.2001.022","volume":"382","author":"F Hanisch","year":"2001","unstructured":"Hanisch, F. O-glycosylation of the mucin type. Biol. Chem. 382, 143\u2013149 (2001).","journal-title":"Biol. Chem."},{"key":"BFnm1627_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","volume":"126","author":"K Ohtsubo","year":"2006","unstructured":"Ohtsubo, K. & Marth, J.D. Glycosylation in cellular mechanisms of health and disease. Cell 126, 855\u2013867 (2006).","journal-title":"Cell"},{"key":"BFnm1627_CR15","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwg007","volume":"13","author":"KG Ten Hagen","year":"2003","unstructured":"Ten Hagen, K.G., Fritz, T.A. & Tabak, L.A. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13, 1R\u201316R (2003).","journal-title":"Glycobiology"},{"key":"BFnm1627_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0006-291X(02)02908-X","volume":"300","author":"H Wang","year":"2003","unstructured":"Wang, H. et al. Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14. Biochem. Biophys. Res. Commun. 300, 738\u2013744 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm1627_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF00702335","volume":"13","author":"P Delannoy","year":"1996","unstructured":"Delannoy, P. et al. Benzyl-N-acetyl-\u03b1-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj. J. 13, 717\u2013726 (1996).","journal-title":"Glycoconj. J."},{"key":"BFnm1627_CR18","doi-asserted-by":"crossref","first-page":"19271","DOI":"10.1016\/S0021-9258(19)47297-9","volume":"264","author":"SF Kuan","year":"1989","unstructured":"Kuan, S.F., Byrd, J.C., Basbaum, C. & Kim, Y.S. Inhibition of mucin glycosylation by aryl-N-acetyl-\u03b1-galactosaminides in human colon cancer cells. J. Biol. Chem. 264, 19271\u201319277 (1989).","journal-title":"J. Biol. Chem."},{"key":"BFnm1627_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"M Wei","year":"2001","unstructured":"Wei, M. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727\u2013730 (2001).","journal-title":"Science"},{"key":"BFnm1627_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1074\/jbc.270.1.387","volume":"270","author":"MP Boldin","year":"1995","unstructured":"Boldin, M.P. et al. Self-association of the \u201cdeath domains\u201d of the p55 tumor necrosis factor (TNF) receptor and Fas\/APO1 prompts signaling for TNF and Fas\/APO1 effects. J. Biol. Chem. 270, 387\u2013391 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnm1627_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1006960004440","volume":"15","author":"JE Hansen","year":"1998","unstructured":"Hansen, J.E. et al. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconj. J. 15, 115\u2013130 (1998).","journal-title":"Glycoconj. J."},{"key":"BFnm1627_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S1097-2765(00)80207-5","volume":"4","author":"S Hymowitz","year":"1999","unstructured":"Hymowitz, S. et al. Triggering cell death: the crystal structure of Apo2L\/TRAIL in a complex with death receptor 5. Mol. Cell 4, 563\u2013571 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1627_CR23","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","volume":"288","author":"FK Chan","year":"2000","unstructured":"Chan, F.K. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351\u20132354 (2000).","journal-title":"Science"},{"key":"BFnm1627_CR24","doi-asserted-by":"publisher","first-page":"18099","DOI":"10.1073\/pnas.0507329102","volume":"102","author":"L Clancy","year":"2005","unstructured":"Clancy, L. et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. USA 102, 18099\u201318104 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1627_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.emboj.7601460","volume":"26","author":"C Feig","year":"2007","unstructured":"Feig, C., Tchikov, V., Schutze, S. & Peter, M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J. 26, 221\u2013231 (2007).","journal-title":"EMBO J."},{"key":"BFnm1627_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ni822","volume":"3","author":"Z Xu","year":"2002","unstructured":"Xu, Z. & Weiss, A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3, 764\u2013771 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnm1627_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm1228","volume":"4","author":"N Haines","year":"2003","unstructured":"Haines, N. & Irvine, K.D. Glycosylation regulates Notch signalling. Nat. Rev. Mol. Cell Biol. 4, 786\u2013797 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm1627_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1074-7613(00)80180-6","volume":"12","author":"JJ Priatel","year":"2000","unstructured":"Priatel, J.J. et al. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12, 273\u2013283 (2000).","journal-title":"Immunity"},{"key":"BFnm1627_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-4165(99)00170-1","volume":"1473","author":"I Brockhausen","year":"1999","unstructured":"Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473, 67\u201395 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm1627_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrd1751","volume":"4","author":"D Dube","year":"2005","unstructured":"Dube, D. & Bertozzi, C. Glycans in cancer and inflammation\u2014potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477\u2013488 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm1627_CR31","first-page":"2775","volume":"63","author":"M Fuster","year":"2003","unstructured":"Fuster, M., Brown, J., Wang, L. & Esko, J. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 63, 2775\u20132781 (2003).","journal-title":"Cancer Res."},{"key":"BFnm1627_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrc1649","volume":"5","author":"M Fuster","year":"2005","unstructured":"Fuster, M. & Esko, J. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526\u2013542 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1627_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/emboj\/18.6.1516","volume":"18","author":"C Ohyama","year":"1999","unstructured":"Ohyama, C., Tsuboi, S. & Fukuda, M. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J. 18, 1516\u20131525 (1999).","journal-title":"EMBO J."},{"key":"BFnm1627_CR34","first-page":"354","volume":"53","author":"A Takada","year":"1993","unstructured":"Takada, A. et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53, 354\u2013361 (1993).","journal-title":"Cancer Res."},{"key":"BFnm1627_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrg1297","volume":"5","author":"E Hoffman","year":"2004","unstructured":"Hoffman, E., Awad, T. & Palma, J. Expression profiling\u2014best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet. 5, 229\u2013237 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"BFnm1627_CR36","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.1158\/1078-0432.CCR-05-1492","volume":"11","author":"R Yauch","year":"2005","unstructured":"Yauch, R. et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res. 11, 8686\u20138698 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1627_CR37","doi-asserted-by":"publisher","first-page":"19401","DOI":"10.1074\/jbc.M413962200","volume":"280","author":"DA Sharp","year":"2005","unstructured":"Sharp, D.A., Lawrence, D.A. & Ashkenazi, A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 280, 19401\u201319409 (2005).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1627","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nm1627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nm1627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:29:34Z","timestamp":1684448974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BFnm1627"],"URL":"https:\/\/doi.org\/10.1038\/nm1627","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}